Recent Articles from Investor Brand Network

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

Kairos Pharma (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on overcoming cancer drug resistance, announced that CEO and Chairman John Yu, MD, will present a corporate overview in person at the H.C. Wainwright 28th Annual Global Investment Conference, taking place Sept. 14-16, 2026, at the Lotte New York Palace Hotel.

This article has been disseminated on behalf of Fairchild Gold Corp. and may include paid advertising.

Recent weeks have seen the news dominated by reports of AI agents going rogue and hacking into sites and systems outside the controlled testing environments created by AI labs like OpenAI and Anthropic. The story of these rogue agents has taken on as many colors as the people narrating it, and we explore some of those narratives.

For many women, UTIs are something they routinely experience. These usually start as a burning sensation or a sudden urge to use the bathroom. For some, there is a sudden onset of discomfort that they just cannot ignore. While many receive a dose of antibiotics after being told what’s bothering them “is just a UTI,” several questions remain in the mind of the woman .

The latest insights from the World Gold Council suggest that gold prices may face additional downside as the current momentum diminishes. This outlook comes amid conflicting signals from the U.S. Treasury Department and the Federal Reserve, which have created a complex environment for the precious metal.

Investor conferences can take a lot of different forms. Some lean heavily toward networking, while others focus primarily on company presentations and scheduled investor meetings.

A federal judge has determined that the Defense Department acted unlawfully when it moved to bar AI firm Anthropic from doing business with the U.S. military.

Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising.

Europe’s wind sector looks set for its best year yet, with 8.8 GW of fresh turbine capacity installed across H1 of 2026 alone, up roughly 30% from the same stretch a year earlier. That pace has WindEurope forecasting 24 gigawatts of new capacity for the full year. This could push the industry meaningfully closer to its stated ambition of adding close to 30 gigawatts annually once the 2030s arrive.

Electric vehicles are having a brutal stretch in the United States . Their share of the new-car market hit a record near 12% last September, right before a $7,500 federal EV incentive went away. By January that share had fallen to 6%, and Cox Automotive figures show sales dropped by a further 20% that month compared with December.

Bitcoin came under renewed pressure as last week ended, falling about 1.4% to roughly $77,000 after reaching around $77,500 earlier in the week. The decline erased a fraction of the crypto’s strong August performance, when it gained almost 25%.

Australia is considering a major change to the way social media platforms use recommendation algorithms. The government is weighing whether users should have to actively choose to use these systems instead of having them switched on automatically when they create an account.

The U.S. and the European Union are taking increasingly different approaches to AI, with Washington pressing for lighter regulation while Brussels moves ahead with enforcement of its new rules.

Nutriband (NASDAQ: NTRB) announced that CEO Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on Sept. 16, 2026, at Nasdaq MarketSite in New York. The summit will bring together biotechnology executives, investors and industry leaders for an evening of thought leadership and networking.

Silo Pharma (NASDAQ: SILO), a developmental-stage biopharmaceutical company focused on novel therapeutics and drug delivery systems with a wholly owned managed AI agent platform, announced that company representatives will participate in the IPAC-RS 2026 Nasal Innovation Forum, taking place Sept. 16-17, 2026, in Jersey City, New Jersey. CEO Eric Weisblum said the forum provides an opportunity to engage with experts in nasal drug development as Silo continues advancing SPC-15’s novel nose-to-brain approach to targeted drug delivery for the treatment of PTSD. Preclinical data showed that the SPC-15 formulation and device met predefined specifications for assay, impurities, pH and microbiological quality through nine months, while six-month accelerated stability data was consistent and aligned with long-term data.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.

Frontieras North America the energy and environmental technology company commercializing FASForm(TM) Solid Carbon Fractionation, announced it has entered into a Letter of Intent (“LOI”) with Cora Terminal, LLC, a joint venture between Watco Companies, LLC and SCH Services, LLC, for phased development of FASForm(TM) production capacity at the Cora Terminal in Rockwood, Illinois. Under the contemplated structure, Frontieras would initially lease approximately 85 acres for a plant designed to process 7,500 tons of coal feedstock per day, with a later expansion to approximately 130 acres for a second plant. At full two-plant buildout, the site would receive approximately 5.5 million net tons of coal feedstock annually and ship products including FASCarbon(TM), ultra-low-sulfur diesel, jet fuel, ammonium sulfate fertilizer, sulfuric acid and naphtha.

Datavault AI (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company focused on data monetization, credentialing, digital engagement, real-world asset (“RWA”) tokenization and spatial audio technologies, issued a statement in response to recently filed shareholder litigation and related notices being circulated by plaintiffs’ law firms. The company said it intends to vigorously defend itself against the claims, a number of which concern subjects previously raised in an Oct. 31, 2025, short-seller report by Wolfpack Research. Datavault AI and CEO Nathaniel Bradley subsequently filed litigation against Wolfpack Research and its founder, Dan David, alleging defamation, false light, tortious interference and unjust enrichment arising from that report. Datavault AI said it stands behind its public disclosures and does not intend to comment further on pending litigation except as appropriate or required by law.

Rail Vision (NASDAQ: RVSN, FSE: C80), an early commercialization stage technology company transforming railway safety through advanced AI-integrated sensing systems, announced new branding for its existing MainLine and ShuntingYard products, which will now be marketed as TrackScout and YardFlow Flex, respectively. TrackScout is the company’s long-range AI perception system for mainline freight and passenger rail networks, detecting and classifying hazards in real time at ranges of up to 2,000 meters, while YardFlow Flex is designed for freight and industrial yards and detects on-track and near-track hazards at distances of up to 200 meters. Both systems incorporate capabilities including switch-state and anomaly detection and are complemented by Rail Vision’s operational intelligence platform, which uses big data analytics, real-time tracking and continuous event recording to provide fleetwide safety and efficiency insights.

This NewsBreak has been disseminated on behalf of Helus Pharma and may include paid advertising.

BOXABL (NASDAQ: BXBL) an innovative technology company transforming the housing market with its modular building systems, highlighted a portfolio of completed and in-progress projects demonstrating deployments of its factory-built housing system nationwide. Projects include a permanent 12-unit park-model RV Casita installation at American Campground in Las Vegas, wildfire relief support in Pasadena, California, a 12-unit stacked Casita project for Catholic Charities in Oklahoma City and the 12-unit Pasadera short-term rental community near Oklahoma State University.

Eco Wave (NASDAQ: WAVE) is a pioneering onshore wave energy company developing technology to convert ocean and sea waves into clean, reliable and cost-efficient electricity. As global electricity demand accelerates—driven in part by the rapid expansion of artificial intelligence, data centers and digital infrastructure—the company believes wave energy can emerge as an important new source of renewable power for the next generation of energy-intensive infrastructure.

Datavault AI(TM) (NASDAQ: DVLT) is an artificial intelligence and data monetization company focused on transforming data and real-world assets into secure, measurable and monetizable digital assets. The company has built an integrated technology ecosystem that combines artificial intelligence, data valuation, tokenization, cybersecurity, high-performance computing and exchange infrastructure to support the full lifecycle of data — from creation and authentication through valuation, licensing, tokenization and monetization.

Mobix Labs (NASDAQ: MOBX), a U.S.-based provider of advanced electronic components and connectivity solutions for aerospace, defense and mission-critical applications, announced its initial production order for components supporting the F-16 Fighting Falcon. The order, placed by a veteran-owned U.S. aerospace sustainment contractor supporting the U.S. Air Force F-16 fleet, includes EMI-filtered connectors manufactured at Mobix Labs military-approved facility in Irvine, California. Initial shipments have already been delivered, with the balance scheduled for delivery in the coming weeks.

Mobix Labs (NASDAQ: MOBX), a U.S.-based provider of advanced electronic components and connectivity solutions for aerospace, defense and mission-critical applications, announced its initial production order for components supporting the F-16 Fighting Falcon. The order, placed by a veteran-owned U.S. aerospace sustainment contractor supporting the U.S. Air Force F-16 fleet, includes EMI-filtered connectors manufactured at Mobix Labs military-approved facility in Irvine, California. Initial shipments have already been delivered, with the balance scheduled for delivery in the coming weeks.

Knightscope (NASDAQ: KSCP), a security technology company building an Autonomous Security Force, announced that Founder, Chairman and CEO William Santana Li will present at a Tribe Public webinar and Q&A event titled “Building America’s Autonomous Security Force With AI, Robotics, and Humans” on Sept. 10 at 11:30 a.m. ET. The presentation will examine Knightscope model combining autonomous machines, AI-driven software and human security professionals into an integrated operation. Knightscope said it currently serves 434 clients across 42 states and its machines have logged more than 4.4 million autonomous hours in the field. The company Autonomous Security Force is scheduled to officially launch at GSX 2026, being held Sept. 14-16 in Atlanta.

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company combining immunology therapeutic development with a revenue-generating contract development and manufacturing organization (“CDMO”), announced a strategic refocusing of its R&D portfolio following the Aug. 31 expiration and termination of its option and license arrangements with PinCell S.r.l. relating to PC111. Scinai said the decision was not driven by any new negative scientific finding regarding PC111 and will allow the company to concentrate R&D resources on its NanoAb platform while preserving capital and management capacity for its CDMO business. Scinai is advancing two IL-17 programs within the NanoAb platform, including an intradermal psoriasis program for which approximately €12 million in grant financing is under evaluation in Poland. The company also reported approximately $3.1 million in committed CDMO customer orders as of Aug. 16 and continues to pursue approximately $5 million in CDMO revenue for 2026, subject to project execution, timing, revenue recognition and additional business opportunities.

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) (FSE: W1H) and may include paid advertising.

Roth Capital Partners is scheduled to host and sponsor more than a dozen investor events from September 2026 through June 2027, including seven ROTH-hosted conferences focused on healthcare, nuclear technology, solar and storage, technology and other growth sectors. Upcoming hosted events include the 5th Annual ROTH Healthcare Opportunities Conference on Sept. 29 in New York, the inaugural ROTH Critical Mass in Emerging Nuclear Technology on Oct. 1 in New York, the 13th Annual ROTH Solar & Storage Symposium at RE+ from Nov. 16-18 in Las Vegas and the 15th Annual ROTH Technology Conference from Nov. 17-18 in New York.

Wearable Devices (NASDAQ: WLDS), a pioneer in artificial intelligence (“AI”)-powered touchless sensing wearables, announced that it will showcase its neural sensing layer for Physical AI and humanoid robotics at Physical AI 2026 in Tel Aviv. The company technology is designed to complement vision-based training data with synchronized signals associated with human movement, muscle activation and intent. Wearable Devices said its multi-channel sEMG array captures motor unit action potentials before movement becomes visible and combines those signals with IMU and PPG data to generate hand-pose tracking, applied force, moment-of-touch and intent labels for Physical AI applications. The company is participating as a sponsor of the Sept. 8 event, which is being held in collaboration with Israel National AI Directorate.

Faraday Future (NASDAQ: FFAI) is a U.S.-based Physical AI ecosystem company dedicated to reshaping the future of robotics and mobility solutions through AI innovation and technologies. FF focuses on two major product strategies within the Embodied AI (“EAI”) robotics business: EAI humanoid and bionic robots, and EAI automotive-focused robots. By building a “Four-Core Full-Stack AI” ecosystem of EAI Brain, Device, Industry Productivity Solutions and Developer Platform, and Data Factory, FFAI aims to create an evolutionary flywheel: scaled device delivery, data collection and training, continuous evolution of the EAI Brain, stronger product capability, and even larger-scale delivery and deployment. Through this flywheel, FF seeks to maximize its commercial value and lead to the advancement of Physical AI. For more information, visit the company’s website at: https://www.ff.com/

Recent world geopolitical events have made one argument impossible to dismiss: Energy systems built around imported feedstocks and foreign supply chains carry risks that domestic production does not. Frontieras North America is working to strengthen its position in that domestic alternative, creating a production system that converts American coal into six essential byproducts, all within U.S. infrastructure and using a feedstock that never crosses a border or passes through a maritime chokepoint.

Cyabra (NASDAQ: CYAB) is an AI-powered narrative intelligence company that helps national security and defense organizations, government agencies, brands, communications agencies, and global enterprises restore trust and authenticity online by analyzing manipulated content, coordinated behaviors, and inauthentic actors. The platform helps teams understand who is operating, how activity is amplified, and where coordinated activity is shaping perception, translating evidence into clear mitigation steps. By reducing ambiguity and misdirected response, Cyabra enables proportionate, evidence-led action when clarity matters most. For more information, visit the company’s website at: https://www.cyabra.com

Researchers from the Washington University School of Medicine in St. Louis have found a way to improve brain cancer treatment: laser therapy . This technology has played an increasingly larger role in brain cancer therapy over the past 15 years as an alternative to open skull surgery. The research team has spent years studying a technique called laser interstitial thermal therapy, or LITT, to improve the overall treatment experience and outcomes for brain cancer patients.

Elon Musk and Mark Zuckerberg have called on G20 countries to support the rapid expansion of data centers needed to power the next stage of artificial intelligence. The technology leaders made their comments during a G20 meeting of technology ministers in Chapel Hill, North Carolina, as countries debate how to manage the fast growth of AI.

Impala Platinum, a South African giant in the global PGM industry, has paid out enhanced dividends to its shareholders after enjoying a year of bulked-up metal prices as PGMs saw their prices soar in a reversal of multiple years of dismal prices.

BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) drugs on the market today can slow the disease down, but none of them stop it, and none of them give patients back what they have already lost. Nearly one million people in the United States, and close to 2.9 million worldwide, live with that reality, watching a disease that can gradually erode mobility, vision, and basic bodily control. That gap has just gotten a serious new challenger. Quantum BioPharma Ltd. (NASDAQ: QNTM) ( Profile ) has received FDA clearance to begin a phase 2 trial of Lucid-MS, a patented, first-in-class drug candidate aimed not at calming the immune system but at protecting and potentially repairing the myelin sheath itself. The clearance sets the stage for what would be the first time in history that a drug candidate built on this specific mechanism is tested in people living with the MS disease, a milestone significant enough that it has already drawn a fresh buy rating from Wall Street analysts. This momentum places Quantum BioPharma solidly in a group of leading companies focused on the treatment of serious diseases and areas of significant unmet medical need across vaccines, ophthalmology and neurological disease, including Sanofi (NASDAQ: SNY), Roche Holding AG (OTCQX: RHHBY), Biogen Inc. (NASDAQ: BIIB) and…

NanoViricides, Inc. (NYSE American: NNVC), a clinical-stage developer of antiviral drugs, announced that its phase II clinical trial evaluating NV-387 Oral Gummies as a treatment for Bundibugyo ebolavirus and other Ebola viruses in the Democratic Republic of Congo (“DRC”) has been registered in the Pan African Clinical Trials Registry under identification number PACTR202608748555077. The company previously received local regulatory approval from ACOREP to begin the trial and said NV-387 has been delivered to the clinical trial site in Ituri province, with first patient dosing anticipated within one to two weeks, barring outbreak-related impediments. The adaptive trial will begin with a single-arm safety and dose run-in before progressing to a randomized, controlled, open-label efficacy evaluation. NanoViricides said NV-387 is an orally administered broad-spectrum antiviral designed to mimic host-side features required by viruses for infection and is also being evaluated in a phase II clinical trial for Mpox in the DRC.

Datavault AI (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company, announced that its Information Data Exchange(R) (“IDE(R)”), NIL Vault (“NILv(TM)”) and American Political Exchange (“APEX(TM)”) are scheduled to launch Sept. 15, marking the company transition from infrastructure development toward commercial deployment. IDE(R), the company flagship exchange platform, is designed to enable data and other real-world assets to be authenticated, valued, tokenized and monetized while allowing owners to retain control of their underlying data. NILv(TM) applies Datavault AI technology to name, image and likeness rights, while APEX(TM) is designed for political data and related information assets. The platforms will also incorporate capabilities from NYIAX, which Datavault AI acquired Aug. 19, including exchange technology, blockchain settlement infrastructure and four issued U.S. patents. CEO Nathaniel Bradley said the company focus following the launch will be driving adoption, scaling the platforms and converting commercial opportunities into revenue.

Disseminated on behalf of LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) and may include paid advertising.

Nutriband (NASDAQ: NTRB), a developer of prescription transdermal pharmaceutical products, announced that it received a Sept. 2 Notice of Publication from the U.S. Patent and Trademark Office (“USPTO”) for commercial brand name trademarks associated with its lead abuse-deterrent fentanyl transdermal system. The trademarks will be published in the USPTO Trademark Official Gazette and, if no objections are filed during the 30-day opposition period, the USPTO is expected to issue a Notice of Allowance. The fentanyl system incorporates Nutriband AVERSA(TM) abuse-deterrent transdermal technology and is being developed as a patch designed to deter abuse and misuse and reduce the risk of accidental exposure to transdermal fentanyl. Nutriband said the product has potential peak annual U.S. sales of $80 million to $200 million, while its AVERSA(TM) technology is protected by patents issued in 46 countries.

Greenland Mines (NASDAQ: GRML) announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company, including plans to spin off its biotechnology division in the fourth quarter of 2026. Nasdaq has formally approved the company application relating to its March 2026 transaction, resolving prior deficiencies and bringing Greenland Mines into full compliance with listing requirements. The company also completed its acquisition of the Sarfartoq project on Sept. 1 following approval by the Government of Greenland. An independent S-K 1300 Initial Assessment for the ST1 deposit estimated a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%. Greenland Mines said planned annual neodymium-praseodymium oxide production from ST1 would equal approximately 34% of current NdPr oxide refining outside China based on 2025 consumption levels during each of the project nine scheduled operating years. The company is also reshaping its board, with Riad El-Dada and Dr. Shalom Hirschman stepping down and capital markets veteran Jason Hawkins joining as Greenland Mines advances Sarfartoq and its Skaergaard palladium-gold-platinum project.

OS Animal Health is a wholly owned subsidiary of OS Therapies Inc. (NYSE American: OSTX) dedicated to improving outcomes for pets with cancer. The company is focused on developing and commercializing OST-HER2 for canine osteosarcoma and is working to re-establish USDA conditional approval to bring innovative immunotherapies to the veterinary oncology market. OST-HER2 is being positioned as the “go-to” option for all HER2 positive cancers in dogs, and eventually for all companion animals. For more information, visit the company’s website at: https://ostherapies.com/

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising.

This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.

American Fusion (OTC: AMFN), developer of the proprietary Texatron(TM) Fusion Engine(TM), reported the filing of 30 additional U.S. patent applications, expanding its intellectual property portfolio to 130 pending U.S. applications. The latest filings cover additional configurations and components of the Texatron(TM) platform, including aluminum fusion-confinement structures, toroidal and rifled chamber geometries, conductive components, helium-3 and deuterium fuel-injection configurations and electronic control systems. American Fusion has set an objective of filing more than 260 U.S. patent applications by the end of 2026, putting the company at approximately half of that target.

The 2026 Disruptive Growth & Life Sciences Conference takes place September 9–10 at The Westin New York Grand Central. There are years when a small-cap investor conference is a nice-to-have. This is not one of them. Two of the sectors that have moved most sharply in 2026, life sciences and the energy and compute infrastructure being built to support artificial intelligence, are both seeing significant activity at the small- and mid-cap end of the market. They are also sectors where understanding individual companies often requires more than reading filings and watching stock charts.

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising.

Interlink Electronics (NASDAQ: LINK) is a leading provider of sensors and printed electronic solutions, boasting 40 years of success in delivering mission-critical technologies across diverse markets. Its customers, including global blue-chip companies, trust the company’s products and solutions, which span various sectors, including medical, industrial, automotive, wearables, IoT, and other specialty markets. Interlink’s expertise in materials science, manufacturing, embedded electronics, firmware, and software enables the company to create custom solutions tailored to customers’ unique needs.

The LGL Group (NYSE American: LGL) is a publicly traded holding company that acquires, owns and builds businesses and makes strategic investments, with an emphasis on critical technologies. LGL Group conducts its business through two complementary activities: Platform Operations and Merchant Investment.

Tonix Pharmaceuticals (NASDAQ: TNXP), a fully integrated, commercial-stage biopharmaceutical company, announced the promotion of Thomas Englese to chief commercial officer, effective immediately. Englese, who has served as executive vice president of commercial operations since September 2024, will continue to oversee sales, marketing, market access and commercial operations for TONMYA, Tonix treatment for fibromyalgia in adults, as well as Zembrace(R) SymTouch(R) and Tosymra(R) for acute migraine in adults. President and CEO Seth Lederman said Englese has been instrumental in building Tonix commercial organization and launching TONMYA, while Englese said the company is focused on expanding access, growing its patient and prescriber base and increasing sales as it broadens the TONMYA launch.

Disseminated on behalf of Numa Numa Resources Inc. and may include paid advertisements.

Market Street Capital is addressing a financing gap facing mid-market U.S. manufacturers as reshoring accelerates and companies seek capital to build, retool and expand domestic production. The firm helps manufacturers structure combinations of senior debt, equipment financing, asset-based lending, mezzanine capital and public incentives to meet the complex funding requirements of expansion projects. Its focus on middle-market companies, including Tier 2 and Tier 3 suppliers, positions it to serve businesses that may not fit traditional bank financing models or have direct access to major federal programs. By coordinating multiple financing sources, collateral arrangements and lender requirements, Market Street aims to help manufacturers turn reshoring opportunities into funded expansion projects.

AOM Capital has provided $3.8 million in bridge financing to a Northeastern U.S. healthcare company, providing near-term liquidity while the operator awaits payment on outstanding healthcare reimbursements. The short-term facility was structured around the company’s pending reimbursement stream, with AOM evaluating outstanding receivables, the expected reimbursement timeline and operating performance. The financing provides working capital to bridge the period between delivery of healthcare services and payment from third-party payors and expands AOM’s activity in healthcare and specialty finance, including bridge, receivables-backed and special-situation transactions.

Rather than pursuing a broad collection of digital-asset initiatives, MindWave Innovations Inc. (NYSE American: APUS) is concentrating its efforts around a defined blockchain ecosystem. The company’s current strategy centers on four interconnected components: MindChain, its native NILA token, MindWaveDAO and a Subnet architecture designed to support specialized blockchain environments.

Datavault AI (NASDAQ: DVLT), an Artificial Intelligence Platform (“AIP”) company focused on transforming data and real-world assets into intelligent, secure and monetizable digital assets, announced that Chairman and Chief Financial Officer Brett Moyer will participate in the Lake Street Capital Markets 10th Annual Best Ideas Growth (“BIG10”) Conference on Sept. 10 at the Metropolitan Club in New York City. Moyer will be available for one-on-one meetings with investors during the conference.

Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics , is building toward a broader role in the rapidly evolving automation and robotics economy. What began with a focus on hospitality automation is developing into a more diversified strategy spanning proprietary software, autonomous robotics, enterprise coordination, and advanced manufacturing.

Nanox (NASDAQ: NNOX), through its U.S.-based subsidiary Nanox Impact Inc., entered into a distribution agreement with Associated X-Ray Imaging Corp. to support deployment of the Nanox.ARC across New England. Under the agreement, Associated X-Ray Imaging will market, distribute and support the FDA-cleared, multisource 3D digital tomosynthesis system, leveraging its regional customer relationships and service infrastructure. The agreement expands Nanox’s U.S. channel partner network and is intended to increase access to the Nanox.ARC in outpatient and community-based clinical settings across targeted markets.

Silver and gold exchange-traded funds faced significant selling pressure at the end of last month as investors reacted to a shift in expectations surrounding U.S. monetary policy. Precious-metal-linked products declined sharply during the session, with some gold and silver ETFs losing more than 3%.

A recent study that was conducted on 5,617 people diagnosed with colorectal cancer found that while it was uncommon for these patients to develop brain metastases, those patients that developed brain metastases had overall shorter survival times than other patients that didn’t develop brain metastases linked to their colorectal cancer.

An electric car’s clean reputation might be masking a less obvious problem sitting right under it: the tires . Gunnlaugur Erlendsson, founder and CEO of Swedish technology company ENSO, argues that tires are among the products everyone relies on without really thinking about, quietly underpinning much of the global economy while causing damage that rarely gets discussed.

Australia made history last year by being the first country in the world to ban children under 16 years of age from accessing social media. Since then, several other countries like Malaysia have imposed similar bans, and many more countries are exploring how to take similar steps. We discuss some of the challenges that are being faced in the countries that have so far imposed social media bans for minors.

Sweden’s wind power sector is picking up fresh backing from one of the world’s biggest corporate energy buyers after American tech company Amazon signed four new long-term agreements to buy carbon-free electricity from wind projects across central and southern Sweden. Together, the new deals add close to 200 MW of fresh carbon-free capacity to the Swedish grid.

Bitcoin hovered around $78,500 after the Japanese yen weakened beyond ¥160 against the USD in Tokyo, adding pressure to already unsettled financial markets. Investor caution was also heightened by a U.S. military strike on Iran, while renewed dollar strength and more restrictive signals from Fed officials continued to influence expectations for interest rates.

A new report has raised concerns about the financial risks surrounding cryptocurrency projects connected to U.S. President Donald Trump, estimating that investors have lost at least $4.7 billion across several ventures.

SS Innovations International (NASD AQ: SSII), a developer of innovative surgical robotic technologies, presents an attractive proposition for investors in the medical-technology sector. The company’s SSi Mantra system is being deployed at an increasing number of hospitals, surgeons are performing thousands of procedures with the platform, and SSII is beginning to establish an installed base outside its home market.

FingerMotion (NASDAQ: FNGR) entered into a non-binding memorandum of understanding with Lyken AI Computing Inc., operating as Lyken.AI, and BlueFlare Energy Solutions Inc. to establish a preferred, non-exclusive framework for matching enterprise artificial intelligence (“AI”) and high-performance computing (“HPC”) demand with potential modular behind-the-meter (“BTM”) capacity evaluated or developed under FingerMotion’s existing BlueFlare alliance. Initially focused on Alberta, British Columbia and Saskatchewan, the framework contemplates FingerMotion as owner-operator and project sponsor, BlueFlare as the Western Canadian development partner and Lyken as the customer-facing demand and managed-services layer. The company said its BlueFlare relationship has progressed from a single-project discussion to a multi-site development program and it is in discussions with multiple natural gas suppliers and midstream counterparties regarding potential firm supply arrangements for planned BTM generation. No definitive gas supply agreement, capacity commitment, customer contract, project financing or expected revenue has been established, and projects will be evaluated individually subject to financing, site control, supply, customer commitments, regulatory approvals and other conditions.

This article has been disseminated on behalf of New Pacific Metals Corp. and may include paid advertising.

Knightscope (NASDAQ: KSCP), the security technology company building the nation’s first Autonomous Security Force, published “The Executive Protection Agent,” a new field brief for chief security officers ahead of the Force’s live debut at GSX 2026, the Global Security Exchange, Sept. 14-16 at the Georgia World Congress Center in Atlanta. The brief outlines Knightscope’s approach to providing continuous protection for principals, families, homes and assets through a unified system rather than separate security vendors and event-based coverage. The Executive Protection Agent is delivered as a licensed capability of the Autonomous Security Force and operates under the ASF-7 escalation model, with Mission Intelligence providing verified, 24/7 monitoring and a consistent command structure, accountability framework and audit trail. Knightscope said it currently serves 434 clients across 42 states and its machines have logged more than 4.4 million autonomous hours in the field.

VERAXA Biotech (NASDAQ: VRXA) a developer of next-generation antibody-based cancer therapies, announced the appointment of Raju Willener as chief financial officer, effective immediately. Willener brings more than three decades of international financial leadership experience spanning global capital markets, investment banking, corporate finance, asset management and strategic leadership. He will report to CEO and Co-Founder Christoph Antz, Ph.D., and is expected to support the company’s capital strategy, strategic opportunities and continued development of its proprietary BiTAC(R) technology platform and oncology pipeline. Prior to joining VERAXA, Willener served as director of corporate development at Exentis Group AG before being appointed CFO in 2025, where he led M&A initiatives, financial strategy and key corporate functions. Earlier in his career, he held senior executive and investment positions overseeing areas including corporate finance, capital markets, investor relations and investment portfolios exceeding CHF 30 billion in assets under management.

Disseminated on behalf of Millennial Potash Corp. (TSX.V: MLP) (OTCQB: MLPNF) and may include paid advertising.